Source Naturals, Promilin Fenugreek Ext, 500mg Yielding 100mg 4 Hydroxyisoleucine, 60 ct
UPC Code: 021078017578
Our supplier for this product is having delays due to a worker shortage. Orders for this product may take up to 2 weeks extra for processing.
Source Naturals Promilin Fenugreek Extract combines two potent extracts; one, a patent pending extract called Promilin, is standardized to contain 20% 4-hydroxyisoleucine; the other is rich in galactomannan fibers. Research suggests that both 4-hydroxyisoleucine and galactomannan fibers help support healthy blood sugar levels when used as part of your diet.
1 tablet with each meal, or as recommended by your health care professional. It is necessary that this product be taken with a meal because it acts in response to glucose intake.
Calcium - 33 mg
Promilin (Standardized Fenugreek Seed Extract) Yielding 100 mg 4-Hydroxyisoleucine - 500 mg
Fenugreek Seed Extract (4:1) - 100 mg
Other Ingredients: dibasic calcium phosphate, modified cellulose gum, colloidal silicon dioxide, magnesium stearate, and stearic acid.
About Source Naturals
Source Naturals was created in 1982 to support each individual's potential to enjoy optimal health. Source Naturals' comprehensive Bio-Aligned Formulas help bring the power of alignment to your body. When formulating, we evaluate the underlying causes of system imbalances, and then provide targeted nutrition to interdependent body systems. Our line of more than 600 products also includes well-researched, single entity nutrients in their highest quality and most bioavailable forms.
Do not use if pregnant or nursing. Keep out of reach of children. Please consult your health care provider if currently under care or treatment. Do not exceed recommended serving. See product packaging for additional safety information.
Individual results may vary. This product is not intended to diagnose, treat, cure or prevent any disease. The statements on this website and all affiliates have not been evaluated by the FDA. Advice on treatment or care of an individual patient should be obtained through consultation with a trained health care practitioner.